Where can I buy Sun Pharmaceutical shares?

Through a broker offering access to the NSE and BSE, holding the share in a demat account in Indian rupees. Some international brokers also offer the share as a CFD, but they are not registered with SEBI and serve Indian clients cross-border.

Is Sun Pharmaceutical listed on the NSE and BSE?

Yes. Sun Pharmaceutical trades under the symbol SUNPHARMA on India's exchanges and is quoted in Indian rupees (₹).

How are gains on Indian shares taxed?

For listed shares with STT, short-term capital gains (held up to 12 months) are taxed at 20% and long-term gains (held over 12 months) at 12.5% above a ₹1,25,000 yearly exemption, for transfers on or after 23 July 2024. This is not tax advice.

Does HelloBrokers publish a price target for Sun Pharmaceutical?

No. We do not publish price targets and we refuse to invent figures or a fake consensus. Where a credible, dated analyst view exists we cite the named source; otherwise we say there is none.

Share · NSE

Should you buy Sun Pharmaceutical shares?

India's largest pharmaceutical company, a global generics and specialty drug maker with a growing branded portfolio. Here is our rating, the honest trade-offs, and how to buy the share from India.

Roch de Montesquieu Updated 24 July 2026

7.1/10 HelloBrokers rating

Key points

India's largest pharmaceutical company.
Global generics plus a growing specialty portfolio.
Large US and emerging-market presence.
Trade-offs: US pricing pressure and regulation.

India's largest pharmaceutical company, a global generics and specialty drug maker with a growing branded portfolio. It is one of the most closely followed names on the Indian market, listed on the NSE (and BSE) and quoted in Indian rupees. Our rating follows the HelloBrokers methodology: we weigh the fundamentals, the competitive position and the risks, and we do not publish made-up price targets or a fabricated analyst consensus. Below we set out what we like, the risks to keep in mind, and the practical ways to buy the share from India through a SEBI-regulated broker.

Strengths

India's largest pharma company
Diversified generics and specialty pipeline
Global footprint including the US
Growing higher-margin specialty business

Watch-outs

US generic-pricing pressure
Regulatory and FDA-inspection risk
R&D and litigation costs
INR and USD currency exposure

Country 🇮🇳 India Listed on the NSE and BSE, quoted in INR.

Market / ticker NSE: SUNPHARMA Standard NSE symbol; also listed on the BSE.

Chair / leadership Dilip Shanghvi (Managing Director) Leadership as publicly reported.

Sector Healthcare · Pharmaceuticals Business classification.

7.1/10

Large-cap pharma leader

India's largest pharmaceutical company, a global generics and specialty drug maker with a growing branded portfolio. Our view weighs its strengths against its risks, without hype and without invented targets.

Best for Investors wanting a defensive Indian pharma leader. Not for Investors avoiding regulatory and pricing risk.

This is analysis, not investment advice. The bull case: india's largest pharma company, diversified generics and specialty pipeline, and it sits among the large-cap leaders of the Indian market.

The bear case: us generic-pricing pressure, and regulatory and fda-inspection risk. As with any single stock, returns are also affected by the rupee for investors outside India.

Overall we see Sun Pharmaceutical as a large-cap pharma leader. It can suit a diversified, long-term portfolio for investors who understand the risks. As always, we do not publish made-up price targets.

There are two main routes, both of which should go through a regulated broker. A broker comparison is below.

Cash / spot

Buy the cash share through a broker

Open an account with a broker and hold the share directly in Indian rupees, with full shareholder rights and any dividends. In India, listed shares are held in a demat account and trades attract Securities Transaction Tax (STT). Capital gains are taxed as short-term (20%) or long-term (12.5% above the yearly ₹1,25,000 exemption) for transfers on or after 23 July 2024. This is the most direct way to invest for the long term. This is not tax advice.

CFD (leveraged)

Trade it as a CFD (leverage)

Some international brokers offer share CFDs. Leverage amplifies both gains and losses, the cost is the spread plus overnight financing, and you do not own the share. These international brokers are not registered with SEBI and serve Indian clients cross-border. CFDs suit short-term traders who understand the risk; most retail CFD accounts lose money.

For most investors, buying the cash share through a regulated broker and holding for the long term is the most suitable approach. Compare brokers below.

To buy Sun Pharmaceutical, favour a regulated broker with low fees and good coverage of Indian shares. Compare them side by side below.

Compare brokers

: Through a broker offering access to the NSE and BSE, holding the share in a demat account in Indian rupees. Some international brokers also offer the share as a CFD, but they are not registered with SEBI and serve Indian clients cross-border.
: Yes. Sun Pharmaceutical trades under the symbol SUNPHARMA on India's exchanges and is quoted in Indian rupees (₹).
: For listed shares with STT, short-term capital gains (held up to 12 months) are taxed at 20% and long-term gains (held over 12 months) at 12.5% above a ₹1,25,000 yearly exemption, for transfers on or after 23 July 2024. This is not tax advice.
: No. We do not publish price targets and we refuse to invent figures or a fake consensus. Where a credible, dated analyst view exists we cite the named source; otherwise we say there is none.

Why trust the HelloBrokers view on this share

We are an independent editorial team. Sun Pharmaceutical does not pay us, and we do not publish invented price targets or a fake analyst consensus. The rating follows our methodology; affiliate links to brokers fund our work but never change the conclusion.

This content is for information only and is not investment advice, a recommendation or an offer. Past performance does not guarantee future results. Investing in shares carries a risk of capital loss; CFDs amplify that risk. Do your own research and consult a qualified professional where needed.

Should you buy Sun Pharmaceutical shares?

Sun Pharmaceutical overview

Sun Pharmaceutical at a glance